Higher dextrose delivery via TPN related to the development of hyperglycemia in non-diabetic critically ill patients.
- Author:
Hosun LEE
1
;
Shin Ok KOH
;
Moo Suk PARK
Author Information
- Publication Type:Original Article
- Keywords: Hyperglycemia; dextrose; parenteral nutrition; critically ill; non-diabetic
- MeSH: APACHE; Blood Glucose; Critical Illness; Diabetes Mellitus; Glucose; Humans; Hyperglycemia; Intensive Care Units; Length of Stay; Linear Models; Nutritional Status; Parenteral Nutrition; Parenteral Nutrition, Total; Retrospective Studies
- From:Nutrition Research and Practice 2011;5(5):450-454
- CountryRepublic of Korea
- Language:English
- Abstract: The beneficial effects of total parenteral nutrition (TPN) in improving the nutritional status of malnourished patients during hospital stays have been well established. However, recent randomized trials and meta-analyses have reported an increased rate of TPN-associated complications and mortality in critically ill patients. The increased risk of complications during TPN therapy has been linked to the development of hyperglycemia, especially during the first few days of TPN therapy. This retrospective study was conducted to determine whether the amount of dextrose from TPN in the 1st week in the intensive care unit (ICU) was related to the development of hyperglycemia and the clinical outcome. We included 88 non-diabetic critically ill patients who stayed in the medical ICU for more than two days. The subjects were 65 +/- 16 years old, and the mean APACHE (Acute Physiology and Chronic Health Evaluation) II score upon admission was 20.9 +/- 7.1. The subjects received 2.3 +/- 1.4 g/kg/day of dextrose intravenously. We divided the subjects into two groups according to the mean blood glucose (BG) level during the 1st week of ICU stay: < 140 mg/dl vs > or = 140 mg/dl. Baseline BG and the amount of dextrose delivered via TPN were significantly higher in the hyperglycemia group than those in the normoglycemia group. Mortality was higher in the hyperglycemia group than in the normoglycemia group (42.4% vs 12.8%, P = 0.008). The amount of dextrose from TPN was the only significant variable in the multiple linear regression analysis, which included age, APACHE II score, baseline blood glucose concentration and dextrose delivery via TPN as independent variables. We concluded that the amount of dextrose delivered via TPN might be associated with the development of hyperglycemia in critically ill patients without a history of diabetes mellitus. The amount of dextrose in TPN should be decided and adapted carefully to maintain blood glucose within the target range.
